| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2012-09-06 21:03:49 UTC |
|---|
| Update Date | 2021-09-14 15:46:18 UTC |
|---|
| HMDB ID | HMDB0029133 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Valylmethionine |
|---|
| Description | Valylmethionine is a dipeptide composed of valine and methionine. It is an incomplete breakdown product of protein digestion or protein catabolism. Dipeptides are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Some dipeptides are known to have physiological or cell-signalling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. |
|---|
| Structure | CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O InChI=1S/C10H20N2O3S/c1-6(2)8(11)9(13)12-7(10(14)15)4-5-16-3/h6-8H,4-5,11H2,1-3H3,(H,12,13)(H,14,15)/t7-,8-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| L-Val-L-met | ChEBI | | Valyl-methionine | ChEBI | | VM | ChEBI | | L-Valyl-L-methionine | HMDB | | N-L-Valyl-L-methionine | HMDB | | N-Valylmethionine | HMDB | | V-m Dipeptide | HMDB | | VM Dipeptide | HMDB | | Val-met | HMDB | | Valine methionine dipeptide | HMDB | | Valine-methionine dipeptide | HMDB | | Valylmethionine | ChEBI |
|
|---|
| Chemical Formula | C10H20N2O3S |
|---|
| Average Molecular Weight | 248.34 |
|---|
| Monoisotopic Molecular Weight | 248.119463686 |
|---|
| IUPAC Name | (2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-(methylsulfanyl)butanoic acid |
|---|
| Traditional Name | (2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-(methylsulfanyl)butanoic acid |
|---|
| CAS Registry Number | 14486-09-0 |
|---|
| SMILES | CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(O)=O |
|---|
| InChI Identifier | InChI=1S/C10H20N2O3S/c1-6(2)8(11)9(13)12-7(10(14)15)4-5-16-3/h6-8H,4-5,11H2,1-3H3,(H,12,13)(H,14,15)/t7-,8-/m0/s1 |
|---|
| InChI Key | YSGSDAIMSCVPHG-YUMQZZPRSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organic acids and derivatives |
|---|
| Class | Carboxylic acids and derivatives |
|---|
| Sub Class | Amino acids, peptides, and analogues |
|---|
| Direct Parent | Dipeptides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Alpha-dipeptide
- Methionine or derivatives
- N-acyl-alpha amino acid or derivatives
- N-acyl-alpha-amino acid
- N-acyl-l-alpha-amino acid
- Valine or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Thia fatty acid
- Branched fatty acid
- Fatty acyl
- Fatty acid
- Fatty amide
- N-acyl-amine
- Amino acid
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid salt
- Amino acid or derivatives
- Carboxylic acid
- Dialkylthioether
- Monocarboxylic acid or derivatives
- Sulfenyl compound
- Thioether
- Amine
- Organic zwitterion
- Organic oxygen compound
- Primary aliphatic amine
- Organic nitrogen compound
- Organic salt
- Hydrocarbon derivative
- Carbonyl group
- Organic oxide
- Organopnictogen compound
- Organonitrogen compound
- Organooxygen compound
- Organosulfur compound
- Primary amine
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | -1.84 | Extrapolated |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M+H]+ | 163.003 | 30932474 | | DeepCCS | [M-H]- | 160.645 | 30932474 | | DeepCCS | [M-2H]- | 193.531 | 30932474 | | DeepCCS | [M+Na]+ | 169.096 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.19 minutes | 32390414 | | Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 3.01 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.7108 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 7.42 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 192.2 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1158.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 229.8 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 86.0 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 151.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 68.9 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 292.6 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 366.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 329.2 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 713.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 306.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 878.9 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 198.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 220.7 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 338.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 426.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 99.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Valylmethionine,1TMS,isomer #1 | CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)O[Si](C)(C)C | 2026.6 | Semi standard non polar | 33892256 | | Valylmethionine,1TMS,isomer #2 | CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O | 2047.9 | Semi standard non polar | 33892256 | | Valylmethionine,1TMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C | 1995.3 | Semi standard non polar | 33892256 | | Valylmethionine,2TMS,isomer #1 | CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O[Si](C)(C)C | 2098.0 | Semi standard non polar | 33892256 | | Valylmethionine,2TMS,isomer #1 | CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C)C(C)C)C(=O)O[Si](C)(C)C | 2035.0 | Standard non polar | 33892256 | | Valylmethionine,2TMS,isomer #2 | CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C | 1993.7 | Semi standard non polar | 33892256 | | Valylmethionine,2TMS,isomer #2 | CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C | 2071.6 | Standard non polar | 33892256 | | Valylmethionine,2TMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C | 2038.9 | Semi standard non polar | 33892256 | | Valylmethionine,2TMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C | 2051.0 | Standard non polar | 33892256 | | Valylmethionine,2TMS,isomer #4 | CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 2193.5 | Semi standard non polar | 33892256 | | Valylmethionine,2TMS,isomer #4 | CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O | 2105.9 | Standard non polar | 33892256 | | Valylmethionine,3TMS,isomer #1 | CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C | 2038.3 | Semi standard non polar | 33892256 | | Valylmethionine,3TMS,isomer #1 | CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C)C(C)C)[Si](C)(C)C | 2106.8 | Standard non polar | 33892256 | | Valylmethionine,3TMS,isomer #2 | CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2188.6 | Semi standard non polar | 33892256 | | Valylmethionine,3TMS,isomer #2 | CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)C(=O)O[Si](C)(C)C | 2181.0 | Standard non polar | 33892256 | | Valylmethionine,3TMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2190.8 | Semi standard non polar | 33892256 | | Valylmethionine,3TMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2211.8 | Standard non polar | 33892256 | | Valylmethionine,4TMS,isomer #1 | CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2232.4 | Semi standard non polar | 33892256 | | Valylmethionine,4TMS,isomer #1 | CSCC[C@@H](C(=O)O[Si](C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C | 2273.0 | Standard non polar | 33892256 | | Valylmethionine,1TBDMS,isomer #1 | CSCC[C@H](NC(=O)[C@@H](N)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2269.5 | Semi standard non polar | 33892256 | | Valylmethionine,1TBDMS,isomer #2 | CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O | 2288.2 | Semi standard non polar | 33892256 | | Valylmethionine,1TBDMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C | 2227.8 | Semi standard non polar | 33892256 | | Valylmethionine,2TBDMS,isomer #1 | CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2538.5 | Semi standard non polar | 33892256 | | Valylmethionine,2TBDMS,isomer #1 | CSCC[C@H](NC(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2457.7 | Standard non polar | 33892256 | | Valylmethionine,2TBDMS,isomer #2 | CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C | 2457.6 | Semi standard non polar | 33892256 | | Valylmethionine,2TBDMS,isomer #2 | CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N)C(C)C)[Si](C)(C)C(C)(C)C | 2491.7 | Standard non polar | 33892256 | | Valylmethionine,2TBDMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C | 2512.4 | Semi standard non polar | 33892256 | | Valylmethionine,2TBDMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C | 2445.4 | Standard non polar | 33892256 | | Valylmethionine,2TBDMS,isomer #4 | CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2661.8 | Semi standard non polar | 33892256 | | Valylmethionine,2TBDMS,isomer #4 | CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O | 2504.0 | Standard non polar | 33892256 | | Valylmethionine,3TBDMS,isomer #1 | CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C | 2740.7 | Semi standard non polar | 33892256 | | Valylmethionine,3TBDMS,isomer #1 | CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@@H](N[Si](C)(C)C(C)(C)C)C(C)C)[Si](C)(C)C(C)(C)C | 2670.4 | Standard non polar | 33892256 | | Valylmethionine,3TBDMS,isomer #2 | CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2901.1 | Semi standard non polar | 33892256 | | Valylmethionine,3TBDMS,isomer #2 | CSCC[C@H](NC(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2732.5 | Standard non polar | 33892256 | | Valylmethionine,3TBDMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2868.4 | Semi standard non polar | 33892256 | | Valylmethionine,3TBDMS,isomer #3 | CSCC[C@@H](C(=O)O)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2749.3 | Standard non polar | 33892256 | | Valylmethionine,4TBDMS,isomer #1 | CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3109.2 | Semi standard non polar | 33892256 | | Valylmethionine,4TBDMS,isomer #1 | CSCC[C@@H](C(=O)O[Si](C)(C)C(C)(C)C)N(C(=O)[C@H](C(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2970.9 | Standard non polar | 33892256 |
|
|---|
| Spectra |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Valylmethionine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylmethionine 10V, Positive-QTOF | splash10-0udj-0980000000-094769a697207ff2997f | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylmethionine 20V, Positive-QTOF | splash10-0udi-4900000000-7a5fb3f37ca40901a600 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylmethionine 40V, Positive-QTOF | splash10-03k9-9100000000-80bbc685b4c44a538bae | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylmethionine 10V, Negative-QTOF | splash10-0002-0090000000-d54026a1955dccfb8618 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylmethionine 20V, Negative-QTOF | splash10-0002-9200000000-98214019143c7c87b3dd | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Valylmethionine 40V, Negative-QTOF | splash10-0002-9000000000-e1d92d2a30bee517d754 | 2021-09-22 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
|---|
| Biological Properties |
|---|
| Cellular Locations | Not Available |
|---|
| Biospecimen Locations | |
|---|
| Tissue Locations | Not Available |
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Colorectal cancer |
|---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|
| Associated OMIM IDs | |
|---|
| External Links |
|---|
| DrugBank ID | Not Available |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB112135 |
|---|
| KNApSAcK ID | Not Available |
|---|
| Chemspider ID | 5361146 |
|---|
| KEGG Compound ID | Not Available |
|---|
| BioCyc ID | Not Available |
|---|
| BiGG ID | Not Available |
|---|
| Wikipedia Link | Not Available |
|---|
| METLIN ID | Not Available |
|---|
| PubChem Compound | 6993038 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 75015 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| MarkerDB ID | Not Available |
|---|
| Good Scents ID | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| Material Safety Data Sheet (MSDS) | Not Available |
|---|
| General References | - Glaser B, Moskvina V, Kirov G, Murphy KC, Williams H, Williams N, Owen MJ, O'Donovan MC: Analysis of ProDH, COMT and ZDHHC8 risk variants does not support individual or interactive effects on schizophrenia susceptibility. Schizophr Res. 2006 Oct;87(1-3):21-7. Epub 2006 Jul 21. [PubMed:16860541 ]
- Ishikawa Y, Mukawa J, Kinjo T, Mekaru S, Miyazato H, Takara E, Kuda H: [Crossed cerebellar diaschisis in putaminal hemorrhage--evaluation by the Xe-133 clearance method]. No To Shinkei. 1994 Apr;46(4):335-40. [PubMed:8024832 ]
- Brunner EJ, Kivimaki M, Siegrist J, Theorell T, Luukkonen R, Riihimaki H, Vahtera J, Kirjonen J, Leino-Arjas P: Is the effect of work stress on cardiovascular mortality confounded by socioeconomic factors in the Valmet study? J Epidemiol Community Health. 2004 Dec;58(12):1019-20. [PubMed:15547064 ]
- Colzato LS, van Muijden J, Band GP, Hommel B: Genetic Modulation of Training and Transfer in Older Adults: BDNF ValMet Polymorphism is Associated with Wider Useful Field of View. Front Psychol. 2011 Sep 1;2:199. doi: 10.3389/fpsyg.2011.00199. eCollection 2011. [PubMed:21909331 ]
- Henquet C, Rosa A, Delespaul P, Papiol S, Fananas L, van Os J, Myin-Germeys I: COMT ValMet moderation of cannabis-induced psychosis: a momentary assessment study of 'switching on' hallucinations in the flow of daily life. Acta Psychiatr Scand. 2009 Feb;119(2):156-60. doi: 10.1111/j.1600-0447.2008.01265.x. Epub 2008 Sep 18. [PubMed:18808401 ]
- Zhang K, Zheng Z, Gao X, Li J, Zhang F: Possible relationship between the COMT gene ValMet polymorphism and psychometric IQ in girls of the Qinba region in China. Neuropsychobiology. 2007;56(2-3):98-103. doi: 10.1159/000112950. Epub 2008 Jan 10. [PubMed:18182829 ]
- Ohta H, Suzuki E, Hinuma Y, Kawamura S, Nemoto M, Hadeishi H: [Effects of hyperoxia, glycerol and ventricular drainage on ICP and CBF in patients with increased ICP due to CSF circulatory-absorbance disturbance]. No To Shinkei. 1987 Mar;39(3):273-9. [PubMed:3580214 ]
- Leuchter AF, McCracken JT, Hunter AM, Cook IA, Alpert JE: Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder. J Clin Psychopharmacol. 2009 Aug;29(4):372-7. doi: 10.1097/JCP.0b013e3181ac4aaf. [PubMed:19593178 ]
- Ohta H: [The effect of hyperoxemia on cerebral blood flow in normal humans]. No To Shinkei. 1986 Oct;38(10):949-59. [PubMed:3098265 ]
- Kuronen P, Sorri MJ, Paakkonen R, Muhli A: Temporary threshold shift in military pilots measured using conventional and extended high-frequency audiometry after one flight. Int J Audiol. 2003 Jan;42(1):29-33. [PubMed:12564513 ]
- Ohta H, Nemoto M, Kawamura S, Hadeishi H, Hinuma Y, Suzuki E: [The effects of hyperoxemia on cerebral blood flow in subarachnoid hemorrhage patients]. No To Shinkei. 1987 Jul;39(7):649-56. [PubMed:3118911 ]
|
|---|